(2R)-3-[(5S)-3-(4-bromo-3-fluorophenyl)-2-oxo-1,3-oxazolidin-5-yl]-2-methyl-2-methylsulfonylpropanoic acid
C14H15BrFNO6S — CID 118050437
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2R)-3-[(5S)-3-(4-bromo-3-fluorophenyl)-2-oxo-1,3-oxazolidin-5-yl]-2-methyl-2-methylsulfonylpropanoic acid
(2R)-3-[(5S)-3-(4-bromo-3-fluorophenyl)-2-oxo-1,3-oxazolidin-5-yl]-2-methyl-2-methylsulfonylpropanoic acid (PubChem CID 118050437) has the molecular formula C14H15BrFNO6S and a molecular weight of 424.24 g/mol. Its IUPAC name is (2R)-3-[(5S)-3-(4-bromo-3-fluorophenyl)-2-oxo-1,3-oxazolidin-5-yl]-2-methyl-2-methylsulfonylpropanoic acid.
Molecular Properties
| Compound Name | (2R)-3-[(5S)-3-(4-bromo-3-fluorophenyl)-2-oxo-1,3-oxazolidin-5-yl]-2-methyl-2-methylsulfonylpropanoic acid |
|---|---|
| PubChem CID | 118050437 |
| Molecular Formula | C14H15BrFNO6S |
| Molecular Weight | 424.24 g/mol |
| Exact Mass | 422.98 |
| IUPAC Name | (2R)-3-[(5S)-3-(4-bromo-3-fluorophenyl)-2-oxo-1,3-oxazolidin-5-yl]-2-methyl-2-methylsulfonylpropanoic acid |
| SMILES | C[C@@](C[C@H]1CN(c2ccc(Br)c(F)c2)C(=O)O1)(C(=O)O)S(C)(=O)=O |
| InChI | InChI=1S/C14H15BrFNO6S/c1-14(12(18)19,24(2,21)22)6-9-7-17(13(20)23-9)8-3-4-10(15)11(16)5-8/h3-5,9H,6-7H2,1-2H3,(H,18,19)/t9-,14+/m0/s1 |
| InChIKey | CQHXXFFCRFURCG-LKFCYVNXSA-N |
| XLogP | 2.19 |
| TPSA | 100.98 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 424.24 |
| LogP ≤ 5 | 2.19 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118050437 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.